Lifeway Foods, Inc. (LWAY): Price and Financial Metrics
LWAY Stock Summary
- Of note is the ratio of Lifeway Foods Inc's sales and general administrative expense to its total operating expenses; 86.53% of US stocks have a lower such ratio.
- With a year-over-year growth in debt of -37.68%, Lifeway Foods Inc's debt growth rate surpasses merely 8.75% of about US stocks.
- In terms of twelve month growth in earnings before interest and taxes, Lifeway Foods Inc is reporting a growth rate of -280.84%; that's higher than only 7.08% of US stocks.
- If you're looking for stocks that are quantitatively similar to Lifeway Foods Inc, a group of peers worth examining would be CALM, EBF, GTS, WIRE, and LGL.
- LWAY's SEC filings can be seen here. And to visit Lifeway Foods Inc's official web site, go to www.lifewaykefir.com.
LWAY Stock Price Chart Interactive Chart >
LWAY Price/Volume Stats
| Current price | $5.70 | 52-week high | $8.89 |
| Prev. close | $5.85 | 52-week low | $1.43 |
| Day low | $5.57 | Volume | 36,099 |
| Day high | $6.19 | Avg. volume | 32,513 |
| 50-day MA | $6.01 | Dividend yield | N/A |
| 200-day MA | $4.72 | Market Cap | 88.94M |
Lifeway Foods, Inc. (LWAY) Company Bio
Lifeway Foods manufactures and sells probiotic, cultured, and functional dairy and nondairy health food products in the United States. The company was founded in 1986 and is based in Morton Grove, Illinois.
LWAY Price Forecast Based on DCF Valuation
| Current Price | DCF Fair Value Target: | Forecasted Gain: |
| $5.70 | $0.91 | -84% |
Below please find a table outlining a discounted cash flow forecast for LWAY, in which we model out valuation assuming a variety of terminal growth rates. To summarize, we found that Lifeway Foods Inc ranked in the 17th percentile in terms of potential gain offered. Our DCF analysis suggests the stock is overvalued by about 84.33%. The most interesting components of our discounted cash flow analysis for Lifeway Foods Inc ended up being:
- In the past 5.14 years, Lifeway Foods Inc has a compound free cash flow growth rate of -0.03%; that's higher than just 15.81% of free cash flow generating stocks in the Consumer Defensive sector.
- The business' balance sheet reveals debt to be 3% of the company's capital (with equity being the remaining amount). Approximately only 13.92% of US stocks with free cash flow have a lower reliance on debt in their capital structure.
| Terminal Growth Rate in Free Cash Flow | Return Relative to Current Share Price |
| 0% | -85% |
| 1% | -85% |
| 2% | -84% |
| 3% | -84% |
| 4% | -84% |
| 5% | -84% |
Want more companies with a valuation profile/forecast similar to that of Lifeway Foods Inc? See MGPI, CVGW, IBA, SAM, and HRL.
Latest LWAY News From Around the Web
Below are the latest news stories about Lifeway Foods Inc that investors may wish to consider to help them evaluate LWAY as an investment opportunity.
Lifeway Foods Introduces New 3.5oz Functional Shot Multipacks and Organic Whole Milk Grassfed KefirBest-selling Kefir Brand Adds Two New Product Lines to Its Probiotic Portfolio Lifeway Functional Kefir Shots Lifeway Mixed Berry and Strawberry Banana Functional Shots Lifeway Organic Grassfed Kefir Lifeway Organic Strawberry Grassfed Kefir MORTON GROVE, Ill., Feb. 18, 2021 (GLOBE NEWSWIRE) -- Lifeway Foods, Inc. (Nasdaq: LWAY), the leading U.S. supplier of kefir and fermented probiotic products to support the microbiome, announces the addition of two new lines to its collection of best-selling kefir products: 3.5oz Functional Shot Multipacks and Organic Grassfed Kefir. As extensions of Lifeway’s kefir portfolio, these new items support Lifeway’s ongoing mission to support overall health from the inside out. Today’s consumers are increasingly interested in functional foods, specificall... |
Lifeway Foods Applauds Recent Scientific Review Highlighting Kefir as a Potential Protective Dietary Supplementation Against Viral InfectionReview suggests utilization of kefir as an inhibitor of expression of proinflammatory cytokines in COVID-19 could be viable policyMORTON GROVE, Ill., Nov. 18, 2020 (GLOBE NEWSWIRE) -- Lifeway Foods, Inc. (Nasdaq: LWAY) (“Lifeway” or “the Company”), the leading U.S. supplier of kefir and fermented probiotic products to support the microbiome commends the recent review published in Biomedicine & Pharmacotherapy where it posits the probiotics in kefir have immune supporting properties that may be of benefit against infections, including COVID-19. With the world awaiting a vaccine to combat the novel coronavirus, consumer demand for products and methods to boost the immune system and suppress viral infections is on the rise. The review discusses the following about kefir, the fermented mil... |
Lifeway Foods, Inc. Reports Third Quarter 2020 ResultsThird Quarter Net Sales Increase 14.6% Year-Over-Year to $26 MillionMORTON GROVE, Ill., Nov. 16, 2020 (GLOBE NEWSWIRE) -- Lifeway Foods, Inc. (Nasdaq: LWAY) (“Lifeway” or “the Company”), the leading U.S. supplier of kefir and fermented probiotic products to support the microbiome, today reported financial results for the third quarter ended September 30, 2020.“I am pleased to report that our growth trajectory accelerated in the third quarter of 2020, with a 14.6% increase in sales compared to the third quarter of 2019,” commented Julie Smolyansky, Lifeway’s President and Chief Executive Officer. “Our core business continues to show improved velocities and our decision to focus on digital engagement to fuel online grocery purchases and grocery list initiatives has paid dividends in a ret... |
Insights into the Kefir Products Global Market to 2027 - Featuring Liberte, Lifeway Foods & Nourish Kefir Among Others - ResearchAndMarkets.comDUBLIN--(BUSINESS WIRE)--The "Kefir Products - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering. The publisher brings years of research experience to the 6th edition of this report. The 188-page report presents concise insights into how the pandemic has impacted production and the buy side for 2020 and 2021. A short-term phased recovery by key geography is also addressed. Global Kefir Products Market to Reach $2.6 Billion by 2027 Amid the COVI |
A Look Into Lifeway Foods's Price Over EarningsIn the current session, Lifeway Foods Inc. (NASDAQ: LWAY) is trading at $3.67, after a 10.7% spike. Over the past month, the … |
LWAY Price Returns
| 1-mo | -9.67% |
| 3-mo | -22.97% |
| 6-mo | 17.53% |
| 1-year | 170.14% |
| 3-year | -14.03% |
| 5-year | -50.17% |
| YTD | 5.36% |
| 2020 | 171.86% |
| 2019 | 5.85% |
| 2018 | -76.50% |
| 2017 | -30.50% |
| 2016 | 3.69% |
Continue Researching LWAY
Want to do more research on Lifeway Foods Inc's stock and its price? Try the links below:Lifeway Foods Inc (LWAY) Stock Price | Nasdaq
Lifeway Foods Inc (LWAY) Stock Quote, History and News - Yahoo Finance
Lifeway Foods Inc (LWAY) Stock Price and Basic Information | MarketWatch
Get Free Updates
Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!
Loading social stream, please wait...